![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Simpson, Eric L.; Pink, Andrew E.; Blauvelt, Andrew; Gooderham, Melinda; Armstrong, April W.; Worm, Margitta; Katoh, Norito; Peris, Ketty; Puig, Luis; Barbarot, Sébastien; Mark, Thomas; Steffensen, Louise Abildgaard; Tindberg, Ann-Marie und Wollenberg, Andreas 
ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]
Blauvelt, Andrew; Langley, Richard G.; Lacour, Jean-Philippe; Toth, Darryl; Laquer, Vivian; Beissert, Stefan; Wollenberg, Andreas; Herranz, Pedro; Pink, Andrew E.; Peris, Ketty; Fangel, Stine; Gjerum, Le; Corriveau, Joshua; Saeki, Hidehisa; Warren, Richard B.; Simpson, Eric und Reich, Kristian
(2022):
Long-term 2-year safety and efficacy of tralokinumab in adults with moderate-to-severe atopic dermatitis: Interim analysis of the ECZTEND open-label extension trial.
In: Journal of the American Academy of Dermatology, Bd. 87, Nr. 4: S. 815-824